damnacanthal has been researched along with Benign Neoplasms in 1 studies
damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity
| Excerpt | Relevance | Reference |
|---|---|---|
| "Damnacanthal was shown to inhibit the oncogene Ras, p56lck tyrosine kinase, NF-KB pathway and induce apoptosis in vitro." | 2.50 | Damnacanthal: a promising compound as a medicinal anthraquinone. ( Abu, N; Ali, NM; Alitheen, NB; Aziz, MY; Ho, WY; Yeap, SK, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu, N | 1 |
| Ali, NM | 1 |
| Ho, WY | 1 |
| Yeap, SK | 1 |
| Aziz, MY | 1 |
| Alitheen, NB | 1 |
1 review available for damnacanthal and Benign Neoplasms
| Article | Year |
|---|---|
Damnacanthal: a promising compound as a medicinal anthraquinone.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Movement; Humans; Morinda; Neoplasms; Photose | 2014 |